4.7 Article

The contribution of cyclooxygenase-1 and-2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

Related references

Note: Only part of the references are listed.
Review Hematology

Long-term management of thrombocytosis in essential thrombocythaemia

Gunnar Birgegard

ANNALS OF HEMATOLOGY (2009)

Review Oncology

Advances in Understanding and Management of Myeloproliferative Neoplasms

Alessandro M. Vannucchi et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2009)

Article Cardiac & Cardiovascular Systems

Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays Implications for Aspirin Resistance

Francesca Santilli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Hematology

Prevalence of polycythemia vera and essential thrombocythemia

Xiaomei Ma et al.

AMERICAN JOURNAL OF HEMATOLOGY (2008)

Article Pharmacology & Pharmacy

Acetylation of prostaglandnin H2 synthases by aspirin is inhibited by redox cycling of the peroxidase

Manju Bala et al.

BIOCHEMICAL PHARMACOLOGY (2008)

Review Critical Care Medicine

New antithrombotic drugs

Jeffrey I. Weitz et al.

CHEST (2008)

Review Critical Care Medicine

Antiplatelet drugs

Carlo Patrono et al.

CHEST (2008)

Article Hematology

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

Francesco Passamonti et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)

Review Medicine, General & Internal

Mechanisms of disease:: Platelet activation and atherothrombosis

Giovanni Davi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Hematology

Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin

S. Guthikonda et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Review Biochemistry & Molecular Biology

Pharmacodynamic of cyclooxygenase inhibitors in humans

Marta L. Capone et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)

Article Hematology

Leukocytosis, JAK2(V617F) Mutation, and Hemostasis in Myeloproliferative Disorders

Marina Marchetti et al.

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2007)

Article Hematology

Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation

Claudio Tripodo et al.

ACTA HAEMATOLOGICA (2007)

Review Medicine, General & Internal

Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis

C Patrono et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

CN Harrison et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

EJ Baxter et al.

LANCET (2005)

Article Hematology

Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis

N Tanaka et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)

Article Medicine, General & Internal

Efficacy and safety of low-dose aspirin in polycythemia vera

R Landolfi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Multidisciplinary Sciences

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

B Rocca et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)